These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38752281)

  • 1. Contingency management as a maintenance intervention in the long-term treatment of substance use disorders.
    Toegel F; Toegel C; Silverman K
    Addiction; 2024 Sep; 119(9):1515-1516. PubMed ID: 38752281
    [No Abstract]   [Full Text] [Related]  

  • 2. Adaptation of contingency management for stimulant use disorder during the COVID-19 pandemic.
    Zastepa E; Sun JC; Clune J; Mathew N
    J Subst Abuse Treat; 2020 Nov; 118():108102. PubMed ID: 32854983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motivation and Contingency Management Treatments for Substance Use Disorders.
    Walter KN; Petry NM
    Curr Top Behav Neurosci; 2016; 27():569-81. PubMed ID: 25762429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Research on Contingency Management for Adolescent Substance Use.
    Stanger C; Lansing AH; Budney AJ
    Child Adolesc Psychiatr Clin N Am; 2016 Oct; 25(4):645-59. PubMed ID: 27613343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying behavioral activation to sustain and enhance the effects of contingency management for reducing stimulant use among individuals with HIV infection.
    Mimiaga MJ; Closson EF; Pantalone DW; Safren SA; Mitty JA
    Psychol Health Med; 2019 Mar; 24(3):374-381. PubMed ID: 30211620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial interventions for stimulant use disorder.
    Minozzi S; Saulle R; Amato L; Traccis F; Agabio R
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD011866. PubMed ID: 38357958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contingency management for substance misuse.
    McQuaid F; Bowden-Jones O; Weaver T
    Br J Psychiatry; 2007 Mar; 190():272; author reply 272. PubMed ID: 17329758
    [No Abstract]   [Full Text] [Related]  

  • 8. Exercise as an Adjunctive Treatment for Substance Use Disorders: Rationale and Intervention Description.
    Weinstock J; Farney MR; Elrod NM; Henderson CE; Weiss EP
    J Subst Abuse Treat; 2017 Jan; 72():40-47. PubMed ID: 27666958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contingency management needs implementation science.
    Becker SJ
    Addiction; 2024 Sep; 119(9):1522-1524. PubMed ID: 38881151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment.
    Mitchell SG; Monico LB; Stitzer M; Matheson T; Sorensen JL; Feaster DJ; Schwartz RP; Metsch L
    J Subst Abuse Treat; 2018 Nov; 94():18-23. PubMed ID: 30243412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closing the research-to-implementation gap for contingency management as an effective intervention for substance use disorders across diverse communities.
    Hirchak K
    Addiction; 2024 Sep; 119(9):1519-1521. PubMed ID: 38770791
    [No Abstract]   [Full Text] [Related]  

  • 12. Mobile telephone-delivered contingency management interventions promoting behaviour change in individuals with substance use disorders: a meta-analysis.
    Getty CA; Morande A; Lynskey M; Weaver T; Metrebian N
    Addiction; 2019 Nov; 114(11):1915-1925. PubMed ID: 31265747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contingency management: utility in the treatment of drug abuse disorders.
    Stitzer ML; Vandrey R
    Clin Pharmacol Ther; 2008 Apr; 83(4):644-7. PubMed ID: 18305456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contingency management for treatment of substance abuse.
    Stitzer M; Petry N
    Annu Rev Clin Psychol; 2006; 2():411-34. PubMed ID: 17716077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contingency Management: New Directions and Remaining Challenges for An Evidence-Based Intervention.
    Rash CJ; Stitzer M; Weinstock J
    J Subst Abuse Treat; 2017 Jan; 72():10-18. PubMed ID: 27746057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between pre-treatment drug use and heterogeneity of psychiatric diagnosis predicts outcomes in outpatients with co-occurring disorders.
    Oluwoye O; Hirchak K; Leickly E; Skalisky J; McPherson S; Srebnik D; Roll JM; Ries RK; McDonell MG
    Psychiatry Res; 2018 Feb; 260():233-235. PubMed ID: 29220679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contingency Management: Using Incentives to Improve Outcomes for Adolescent Substance Use Disorders.
    Stanger C; Budney AJ
    Pediatr Clin North Am; 2019 Dec; 66(6):1183-1192. PubMed ID: 31679606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contingency management treatments: controversies and challenges.
    Petry NM
    Addiction; 2010 Sep; 105(9):1507-9. PubMed ID: 20707772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of behavioral contingency management in drug abuse treatment.
    Bigelow GE; Stitzer ML; Liebson IA
    NIDA Res Monogr; 1984; 46():36-52. PubMed ID: 6427623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.